Having joined Morningside in 2013, Dr. Lu Huang is currently in charge of Morningside Ventures' healthcare investment activities. With over 15 years' VC industry expertise, she has led over 30 healthcare/life science investments in greater China and North America, ranging from bio-pharmaceutical, medical devices and in-vitro diagnostics sectors to healthcare services and IT. Before joining Morningside, Dr. Huang served as a Marketing Associate in the Public Relations & Marketing group at Continuum Health Partners in New York City, which provides integrated healthcare management services throughout the New York metropolitan region.